Ofranergene obadenovec (VB-111) an anti-cancer gene therapy induces immunotherapeutic effect in platinum resistant ovarian cancer: Histopathology findings

Journal article

Peer reviewed

R. Shapira-Frommer, I. Barshack, Y.C. Cohen, T. Rachmilewitz Minei, N. Yakov, B.J. Monk and R.T. Penson

Gynecologic oncology, Vol.154, pp.231-232

06/2019

Metrics

1 Record Views

Title: Ofranergene obadenovec (VB-111) an anti-cancer gene therapy induces immunotherapeutic effect in platinum resistant ovarian cancer: Histopathology findings
Creators: R. Shapira-Frommer - Sheba Medical Center
I. Barshack - Sheba Medical Center
Y.C. Cohen - Vascular Biogenics
T. Rachmilewitz Minei - Vascular Biogenics
N. Yakov - Vascular Biogenics
B.J. Monk - University of Arizona
R.T. Penson - Massachusetts General Hospital
Publication Details: Gynecologic oncology, Vol.154, pp.231-232
Publisher: Elsevier Inc
Identifiers: 991005969031002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article